The Single-Cell Genome Sequencing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Single-Cell Genome Sequencing Global Market Report 2024 showed a significant increase in market size. The market grew from $2.49 billion in 2024 to $2.84 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%.
The global Single-Cell Genome Sequencing market is predicted to reach $5.04 billion by 2029, expanding at a compound annual growth rate (CAGR) of 15.4%.
Download Your Free Sample of the 2025 Single-Cell Genome Sequencing Market Report and Uncover Key Trends Now!The key drivers in the single-cell genome sequencing market are:
• Increasing prevalence of autoimmune and neurological disorders
• Government initiatives and funding support
• Expansion of contract research organizations (CROs)
• Rising awareness and potential of single-cell RNA sequencing (scRNA-seq) technology
The single-cell genome sequencing market covered in this report is segmented –
1) By Type: Instruments, Reagents
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas
4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications
5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users
The key trends in the single-cell genome sequencing market are:
• Advancements in single-cell sequencing technologies are a key emerging trend.
• The development of single-cell multi-omics technologies is shaping the market.
• There are increased collaborative initiatives to fast-track advancements in the field.
• The market is also being shaped by innovative solutions and partnerships between key players.
The major players in the single-cell genome sequencing market are:
• F Hoffmann La Roche Ltd
North America was the largest region in the single-cell genome sequencing market in 2024